A Research Trial on Weekly Insulin vs. Daily Insulin
Phase 3
877
about 1.4 years
18+
103 sites in AL, CA, CO +28
About this study
Researchers are testing whether a weekly insulin, called insulin icodec, helps reduce blood sugar compared to daily insulin glargine, both in combination with insulin aspart, in adults with type 1 diabetes. The trial will last for about 8.5 months and involve approximately 877 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Insulin aspart
- 2.Receive Insulin glargine
- 3.Receive Insulin icodec
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
insulin aspart, insulin glargine (Long-acting insulin; helps glucose uptake into cells)
injection
Primary: Change in glycosylated haemoglobin (HbA1c)
Secondary: Change in body weight
Endocrinology